The effects of Ankaferd, a hemostatic agent, on wound healing

Basit Öğe Kaydı
dc.authoridTurkmen, Samdanci, Emine/0000-0002-0034-5186
dc.authorwosidSarac, Gulbahar/ABF-3119-2020
dc.authorwosidTurkmen, Samdanci, Emine/ABH-4716-2020
dc.contributor.authorSezgin, Sevgi Ozbaysar
dc.contributor.authorSarac, Gulbahar Ceylan
dc.contributor.authorSamdanci, Emine
dc.contributor.authorSenol, Mustafa
dc.date.accessioned2024-08-04T20:41:16Z
dc.date.available2024-08-04T20:41:16Z
dc.date.issued2015
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground and Design: There have been a lot of topical and systemic agents to provide an ideal scar formation and to decrease the periods of wound healing process by affecting the factors of healing (inflammatory cells, thrombocytes, extracellular matrix etc.). In this study, we investigated the effects of Ankaferd on wound healing. Materials and Methods: Wounds were created with 8 mm punch biopsy knots on the back of 32 rats which were separated into 4 groups of 9 rats. No treatment was done in group D which was the control group while group A received topical Ankaferd treatment twice a day; group B treated with silver sulfadiazine twice a day, and group C put on base cream, which did not include any active agent, twice a day. The rats were followed for 15 days macroscopically and examined histopathologically on days 0., 3., 7., and 15. by taking biopsy specimens. Result: At the end of our study, it was detected that Ankaferd accelerated the healing process in comparison to control and base cream groups according to the macroscopic and histopathologic results. Additionally, similar to this situation, it was observed that the healing process in silver sulfadiazine group was faster than in control and base cream groups. Conclusion: More experimental and clinical studies in larger populations are needed to prove and confirm its efficacy.en_US
dc.identifier.doi10.4274/turkderm.94758
dc.identifier.endpage221en_US
dc.identifier.issn2717-6398
dc.identifier.issn2651-5164
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-84944395744en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage218en_US
dc.identifier.urihttps://doi.org/10.4274/turkderm.94758
dc.identifier.urihttps://hdl.handle.net/11616/97015
dc.identifier.volume49en_US
dc.identifier.wosWOS:000369629100009en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherDeri Zuhrevi Hastaliklar Dernegien_US
dc.relation.ispartofTurkderm-Turkish Archives of Dermatology and Venerologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnkaferden_US
dc.subjectwound healingen_US
dc.subjecthemostatic agenten_US
dc.titleThe effects of Ankaferd, a hemostatic agent, on wound healingen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu